Cellectis (CLLS)
3.25
+0.07 (2.20%)
Upcoming Events
Latest Headlines
Cellectis receives FDA RMAT designation for blood cancer therapy
June 9, 2026 4:31 PM - StreetInsider
Barclays initiates oncology-focused biotechs with positive outlook
May 28, 2026 11:05 AM - StreetInsider
Barclays Starts Cellectis (CLLS) at Overweight
May 28, 2026 3:36 AM - StreetInsider
Cellectis (CLLS) Tops Q1 EPS by 8c
May 11, 2026 4:45 PM - StreetInsider
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
May 4, 2026 7:00 AM - Globe NewsWire
Cibus elects Thomas Urban to board of directors
April 15, 2026 7:01 AM - StreetInsider
Cibus Announces the Election of Thomas Urban to Board of Directors
April 15, 2026 7:00 AM - Globe NewsWire
Cellectis (CLLS) Reiterated at Market Outperform by Citizens After MRD Clearance
April 14, 2026 5:05 AM - StreetInsider
Cellectis (CLLS) Reiterated at Market Outperform by Citizens: 2025 Pipeline Updates Good
March 23, 2026 4:46 AM - StreetInsider
Form 20-F Cellectis S.A. For: Dec 31
March 20, 2026 6:04 AM - SEC Filing
Form 6-K Cellectis S.A. For: Mar 19
March 20, 2026 6:04 AM - SEC Filing
Full Article List
